The CDTRP Is a Recipient of the CIHR Intervention Trial in Inflammation for Chronic Conditions – Knowledge Mobilization Hub grant
We are thrilled to share two exciting successes for the CDTRP community!
We are pleased to announce that the CDTRP team, led by Executive Director, Dr. Patricia Gongal, is the recipient of the Intervention Trial in Inflammation for Chronic Conditions – Knowledge Mobilization Hub grant! Building on CDTRP’s expertise and infrastructure in Knowledge Mobilization, the KM Hub will support the four funded project teams to improve the quality and relevance of results for knowledge users, and accelerate improving care for patients. The KM Hub will support the translation of the four intervention trials (including one led by the Levings team, below) for better prevention and care policies, practices, and services to address inflammation across Canada.
On behalf of the CDTRP Leadership team, we are delighted to congratulate Dr. Gongal and the CDTRP team on their successful grant, which highlights our network’s strengths in collaboration, grant development, knowledge mobilization, communications, and partnership development.
Equally, we are delighted to celebrate Dr. Megan Levings and her team for receiving a team grant for the groundbreaking project Allogeneic Regulatory T Cell Therapy to Prevent Graft-versus-Host Disease (GVHD). The project will conduct a clinical trial in humans to determine if thymus T cells are a safe and effective way to prevent chronic inflammation after bone marrow transplantation. This project represents an exciting milestone for CDTRP, as it originated during the early days of the network with a focus on basic immunology and methods development. Now, it has progressed to a clinical trial in humans—a step toward a potential new therapy for GVHD.
Congratulations to Drs. Gongal, Levings, and their teams for these successes! Learn more about the projects here.